- Trials with a EudraCT protocol (56)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
56 result(s) found for: Kt V.
Displaying page 1 of 3.
EudraCT Number: 2004-000081-13 | Sponsor Protocol Number: BA 17284 | Start Date*: 2004-09-07 |
Sponsor Name:F Hoffmann-La Roche Ltd | ||
Full Title: A randomized, controlled, open-label, multi-center, parallel group study to demonstrate efficacy and safety of RO0503821 when administered with pre-filled syringes for the maintenance treatment of ... | ||
Medical condition: Patients with Chronic Kidney Disease who are on dialysis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2006-002589-20 | Sponsor Protocol Number: CALMAG-01 | Start Date*: 2007-12-14 | |||||||||||
Sponsor Name:Fresenius Medical Care Deutschland GmbH | |||||||||||||
Full Title: Evaluation of Calcium Acetate/Magnesium Carbonate (OsvaRen®) compared to Sevelamer (Renagel®) in Haemodialysis Patients | |||||||||||||
Medical condition: Elevated serum phosphate levels (hyperphosphataemia) in patients with chronic renal failure on dialysis (haemodialysis, peritoneal dialysis) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: PT (Completed) ES (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-000673-57 | Sponsor Protocol Number: PRO-RENAL-REG-063 | Start Date*: 2004-11-15 | |||||||||||
Sponsor Name:Baxter Healthcare S.A. | |||||||||||||
Full Title: Efficacy and Safety of Epoetin-Omega i.v. for Treatment of Anemia in Hemodialyzed Patients Hyporesponsive to a Previous Epoetin Beta i.v. Treatment: a Randomized, Parallel Group Trial. | |||||||||||||
Medical condition: Anaemia in End Stage Renal Disease (ESRD) Hemodialyzed Patients Hyporesponsive to a Previous Epoetin Beta i.v. Treatment | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-004176-22 | Sponsor Protocol Number: IMPURE-Study | Start Date*: 2017-04-28 |
Sponsor Name:Medizinische Universität Graz | ||
Full Title: IMProving Ultrafiltration and REmoval of uremic toxins by adapted automated peritoneal dialysis in a single center study (IMPURE-Study). | ||
Medical condition: Chronic kidney disease G5D | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2004-002108-14 | Sponsor Protocol Number: PD-BLS-01-EU | Start Date*: 2005-06-22 |
Sponsor Name:Fresenius Medical Care Deutschland GmbH. | ||
Full Title: Multizentrische Studie mit einer Niedrig-Natrium Peritonealdialyse-Lösung bei hypertensiven od. antihypertensiv behandelten CAPD Patienten auf balance Lösung | ||
Medical condition: | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2007-003364-21 | Sponsor Protocol Number: MCI-196-E11 | Start Date*: 2009-06-22 | |||||||||||
Sponsor Name:Mitsubishi Tanabe Pharma Corporation | |||||||||||||
Full Title: A Phase III, Multicentre, Double-blind, Double-Dummy, Randomised, Flexible-dose, Comparative Study of MCI-196 versus Simvastatin for the Treatment of Dyslipidaemia in Subjects with Chronic Kidney D... | |||||||||||||
Medical condition: Dislipidaemia in subjects with Chronic Kidney Disease on Dialysis. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: LT (Completed) LV (Completed) DK (Completed) IT (Completed) BG (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-003330-15 | Sponsor Protocol Number: MCI-196-E10 | Start Date*: 2007-01-30 | |||||||||||
Sponsor Name:Mitsubishi Tanabe Pharma Corporation | |||||||||||||
Full Title: A Phase III, Multicentre, Open Label, Flexible dose, Long term Safety Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis with Hyperphosphataemia (incorporating a Comparison wit... | |||||||||||||
Medical condition: Hyperphosphataemia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) AT (Completed) CZ (Completed) FR (Completed) ES (Completed) IT (Completed) DE (Completed) GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-003323-37 | Sponsor Protocol Number: MCI-196-E07 | Start Date*: 2007-01-29 | |||||||||||
Sponsor Name:Mitsubishi Tanabe Pharma Corporation | |||||||||||||
Full Title: A Phase III, Randomised, Double-blind, Multi-centre, Withdrawal Study comparing MCI-196 versus Placebo in Chronic Kidney Disease Stage V Subjects on Dialysis with Hyperphosphataemia (Incorpora... | |||||||||||||
Medical condition: Hyperphosphataemia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) AT (Completed) CZ (Completed) FR (Completed) DE (Completed) IT (Completed) GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-003324-11 | Sponsor Protocol Number: MCI-196-E09 | Start Date*: 2007-03-28 | |||||||||||
Sponsor Name:Mitsubishi Tanabe Pharma Corporation | |||||||||||||
Full Title: A Phase III, Double-blind, Multi-centre, Randomised, Parallel Group Design, Placebo-controlled, Flexible Dose Study of MCI-196 in Combination with a Calcium-based Phosphate Binder in Chronic Kidney... | |||||||||||||
Medical condition: Hyperphosphataemia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Prematurely Ended) AT (Completed) GB (Completed) FR (Completed) ES (Completed) IT (Prematurely Ended) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-001930-17 | Sponsor Protocol Number: CR845-CLIN3103 | Start Date*: 2018-09-20 |
Sponsor Name:Cara Therapeutics INC | ||
Full Title: A MULTICENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY TO EVALUATE THE SAFETY AND EFFICACY OF INTRAVENOUS CR845 IN HEMODIALYSIS PATIENTS WITH MODERATE-TO-SEVERE PRURITUS, WITH A 52... | ||
Medical condition: PRURITUS, | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: HU (Completed) CZ (Completed) GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2018-003899-13 | Sponsor Protocol Number: NL65803.078.18 | Start Date*: 2018-12-20 |
Sponsor Name: | ||
Full Title: The effect of IntraDialytic Parenteral Nutrition on nutritional status and quality of life in hemodialysis patients | ||
Medical condition: Malnutrition / Sarcopenia (loss of muscle mass) in hemodialyse patients. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2007-002380-27 | Sponsor Protocol Number: ML21040 | Start Date*: 2007-09-05 | |||||||||||
Sponsor Name:Roche s.r.o. | |||||||||||||
Full Title: A single arm open label study to assess the efficacy, safety and tolerability and of once-monthly administration of intravenous C.E.R.A. for the maintanance of haemoglobin levels in dialysis patien... | |||||||||||||
Medical condition: Chronic renal anaemia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-000678-30 | Sponsor Protocol Number: PRO-RENAL-REG-056 | Start Date*: 2004-11-22 | |||||||||||
Sponsor Name:Baxter Healthcare S.A. | |||||||||||||
Full Title: An Evaluation of the Efficacy of Epo-Omega in Treatment of Anaemia in ESRD Patients When Administered by Thrice Weekly Intravenous Injection: A Dose Dependency Evaluation. | |||||||||||||
Medical condition: Anaemia in End Stage Renal Disease (ESRD) hemodialyzed Patients | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-004572-35 | Sponsor Protocol Number: CR845-CLIN3105 | Start Date*: 2019-06-17 |
Sponsor Name:Cara Therapeutics, Inc. | ||
Full Title: An Open-Label, Multicenter Study to Evaluate the Safety and Effectiveness of Intravenous CR845 in Hemodialysis Patients with Moderate-to-Severe Pruritus | ||
Medical condition: Moderate-to-Severe Pruritus in Hemodialysis Patients | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: HU (Completed) CZ (Completed) PL (Completed) ES (Completed) | ||
Trial results: View results |
EudraCT Number: 2007-007758-70 | Sponsor Protocol Number: NH19707 | Start Date*: 2008-06-24 | |||||||||||
Sponsor Name:F. Hoffmann-La Roche Ltd | |||||||||||||
Full Title: An open-label multi-center, multiple dose study to determine the optimum starting dose of intravenous MIRCERA® for maintenance treatment of anemia in pediatric patients with chronic kidney disease ... | |||||||||||||
Medical condition: Anemia associated with chronic kidney disease in pediatric patients (CKD) on hemodialysis | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) DE (Completed) ES (Completed) FR (Completed) HU (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-004183-21 | Sponsor Protocol Number: IP-001-18 | Start Date*: 2022-08-19 | |||||||||||
Sponsor Name:Iperboreal Pharma Srl | |||||||||||||
Full Title: A Study to Evaluate the EffIcacy and Safety of XyloCore, a Glucose Sparing Experimental Solution, for Peritoneal Dialysis | |||||||||||||
Medical condition: End-Stage Renal Disease (ESRD) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) IT (Restarted) DK (Ongoing) ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-006535-53 | Sponsor Protocol Number: MCI-196-E08 | Start Date*: 2007-08-09 | ||||||||||||||||
Sponsor Name:Mitsubishi Tanabe Pharma Corporation | ||||||||||||||||||
Full Title: A Phase III, Multi-centre, Double-blind, Randomised, Placebo-controlled, Multiple Fixed-dose Study of MCI-196 versus Placebo in Chronic Kidney Disease Stage V Subjects on Dialysis with Hyperphospha... | ||||||||||||||||||
Medical condition: Hyperphosphataemia and dyslipidaemia | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: HU (Completed) IT (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2010-021665-68 | Sponsor Protocol Number: Citrasate01 | Start Date*: 2010-10-06 | ||||||||||||||||
Sponsor Name:University Hospital Antwerp | ||||||||||||||||||
Full Title: Comparison of Slow Efficiency dialysis (SLEDD) with Unfractionated Heparin versus Citrasate in Critically Ill Patients | ||||||||||||||||||
Medical condition: To compare the feasability, safety and efficacy of Sustained Slow Efficiency Dialys (SLEDD) using regional anticoagulation with Citrasate compared to systemic anticoagulation with Unfractionated He... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: BE (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-004779-39 | Sponsor Protocol Number: NH19708 | Start Date*: 2018-02-26 | ||||||||||||||||
Sponsor Name:Roche Farma S.A(Soc unipersonal)que realiza el ensayo en España y que actua como representante F.Hoffmann-La Roche LTD. | ||||||||||||||||||
Full Title: AN OPEN-LABEL, SINGLE-ARM, MULTICENTER STUDY TO ASCERTAIN THE OPTIMAL STARTING DOSE OF MIRCERA® GIVEN SUBCUTANEOUSLY FOR THE MAINTENANCE TREATMENT OF ANEMIA IN PEDIATRIC PATIENTS WITH CHRONIC KIDNE... | ||||||||||||||||||
Medical condition: Chronic renal anemia | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Completed) LT (Completed) HU (Completed) FR (Completed) PL (Completed) IT (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2010-022011-19 | Sponsor Protocol Number: PA-CL-05A | Start Date*: 2011-02-21 | ||||||||||||||||
Sponsor Name:Vifor (International) Inc. | ||||||||||||||||||
Full Title: An Open-label, Randomised, Active-controlled, Parallel Group, Multicentre, Phase 3 Study to Investigate the Safety and Efficacy of PA21 Compared with Sevelamer Carbonate Followed by a Randomised Co... | ||||||||||||||||||
Medical condition: Control of hyperphosphataemia in patients with chronic kidney disease on dialysis | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Completed) CZ (Completed) LV (Completed) LT (Completed) SE (Completed) AT (Completed) DE (Completed) BE (Completed) | ||||||||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.